Clinical Trials
GenoMed to offer free clinical trial for mumps
Published in Medical Letter on the CDC and FDA, May 17th, 2006
GenoMed believes a class of safe, already existing blood pressure pills may be a near-universal viral antidote, making vaccines and antiviral drugs unnecessary for most viruses except for the tiny fraction of the population which is immunosuppressed. GenoMed's approach has been successful for treating West Nile virus encephalitis in humans for the past 3 summers, and in birds for the past 2 summers. The first 8 patients were published in a peer-reviewed medical journal in 2004.
Said...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Allergy & Immunology
Competition ELISA is sensitive for detection of small allergen quantities - Epidemiology
Analysis of deaths with unknown cause in mortality analyses is discussed - Food-Borne Illness
Analyzing Campylobacter species on turkey farms benefits from multiple typing methods - Stroke
Preeclampsia increases risk of ischemic stroke among young women - Tuberculosis
Public-private collaborations can improve tuberculosis control in India - Adverse Drug Reaction
Adverse events after hepatitis A/B combination vaccine reported - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
